D. E. Shaw & Co., Inc. Ars Pharmaceuticals, Inc. Comm Transaction History
D. E. Shaw & Co., Inc.
- $122 Billion
- Q4 2024
A detailed history of D. E. Shaw & Co., Inc. transactions in Ars Pharmaceuticals, Inc. Comm stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 76,732 shares of SPRY stock, worth $0. This represents 0.0% of its overall portfolio holdings.
Number of Shares
76,732
Previous 80,548
4.74%
Holding current value
$0
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions